In hepatocellular carcinoma, HEG1 has been reported to promote the invasion, metastasis, and epithelial‐mesenchymal transition of HCC by activating Wnt/β‐catenin signaling pathway, so it has been considered as a potential prognostic marker and therapeutic target for HCC.14 The gene discussed is HEG1; the disease is hepatocellular carcinoma.